Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > TLD1433 World Class

<< Previous

Bullboard Posts

Next >>

Comment by Donein25on Aug 12, 2024 8:40am

229 Views

Post# 36174119

RE:RE:RE:RE:RE:RE:TLD1433 World Class

This is the first occassion I recall of seeing "75 patients" mentioned as part of the enrollment plan...for years the plan has always been 100 patients at least. This change should not be underestimated! And it certainly could not have been made without some guidance from FDA. Very interesting.

<< Previous

Bullboard Posts

Next >>

5 steps to mastering risk management in the stock market